Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-14

Clinical Trial Update: Prospective Clinical Study on Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes for the Treatment of Childhood Autism [Phase 1, Phase 2]

View source ↗

Summary

A prospective Phase 1/Phase 2 clinical study is evaluating whether exosomes derived from human umbilical cord mesenchymal stem cells can treat Autism Spectrum D…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes (mesenchymal stem cell-derived exosome)

Snippet

Sponsor: Dongfang People's Hospital | Conditions: Autism Spectrum Disorder (ASD, Prospective Study | Phase 1, Phase 2 | Status: RECRUITING